| Walter Dale Sharp, RPH | |
|
902 S Gloster St, Tupelo, MS 38801-6312 | |
| (662) 844-1318 | |
| (662) 844-1408 |
| Full Name | Walter Dale Sharp |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 902 S Gloster St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255608253 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | E06445 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Walter Dale Sharp, RPH 902 S Gloster St, Tupelo, MS 38801-6312 Ph: (662) 844-1318 | Walter Dale Sharp, RPH 902 S Gloster St, Tupelo, MS 38801-6312 Ph: (662) 844-1318 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.
Quality measures announced today by the Core Quality Measures Collaborative represent a step forward in reducing paperwork and confusion while also allowing providers to focus on measures that impact patient outcomes, the American College of Cardiology (ACC) and the American Heart Association (AHA) said in support of implementation of the proposed cardiovascular measures. But the groups expressed reservations about blood pressure targets included in the measures.
A University of Florida study of middle-aged and older adults finds those who unknowingly carry methicillin-resistant Staphylococcus aureus, or MRSA, on their skin are twice as likely to die within the next decade as people who do not have the bacteria.
A research team led by biochemist Scott Garman at the University of Massachusetts Amherst has discovered a key interaction at the heart of a promising new treatment for a rare childhood metabolic disorder known as Fabry disease.
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.
› Verified 6 days ago
Millie Dyson, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 834 Barnes Crossing Rd, Tupelo, MS 38804 Phone: 662-840-8462 | |
Riyad Alwaisi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1306 Michael Cir, Tupelo, MS 38801 Phone: 313-642-3728 | |
Mr. Thomas Franklin Sloan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3929 N Gloster St, Tupelo, MS 38804 Phone: 662-840-5546 Fax: 662-840-8379 | |
Ryan Sewell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3929 N Gloster St, Tupelo, MS 38804 Phone: 662-840-5546 | |
Sarah Kathryn Morris, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 316 S Gloster St, Tupelo, MS 38801 Phone: 662-350-6921 | |
Dr. Mary Margaret Via, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 738 S Gloster St, Tupelo, MS 38801 Phone: 662-844-0432 | |
Mrs. Terri Adderholt Driskill, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1244 East Main Street, Address Line 2, Tupelo, MS 38804 Phone: 662-844-7811 Fax: 662-844-7876 |